Vaginal health is far more than the presence or absence of pathogens.

The vaginal environment is a dynamic ecosystem influenced by the interaction between microbial communities, opportunistic microorganisms, host factors, and antimicrobial resistance mechanisms. Changes within this ecosystem may contribute to conditions such as bacterial vaginosis (BV), recurrent vaginal infections, and challenges in clinical management.

For decades, vaginal health assessment has relied on conventional methods such as microscopy, vaginal pH testing, and Amsel’s clinical criteria. These approaches remain important tools in clinical practice; however, they may have limitations when evaluating complex microbial changes, mixed microbial profiles, and antimicrobial resistance-related information.

As scientific understanding of the vaginal microbiome continues to advance, international guidelines and clinical recommendations increasingly highlight the importance of considering microbial balance alongside pathogen detection.

To support this evolving diagnostic landscape, Macro & Micro-Test introduces the Women’s Health Advanced Nucleic Acid Detection Kit, a comprehensive molecular solution designed to detect 20 clinically relevant targets in a single assay, providing insights into vaginal microbiota-associated microorganisms, opportunistic pathogens, and antimicrobial resistance (AMR) markers.

I. From Pathogen Detection to Comprehensive Vaginal Ecosystem Assessment

A New Perspective on Women’s Vaginal Health

Bacterial vaginosis (BV) is one of the most common causes of abnormal vaginal discharge among reproductive-age women, with global prevalence estimated at approximately 23–29%.

According to the World Health Organization (WHO), BV is associated with an imbalance in the vaginal microbiota, where changes in microbial community composition may disrupt the normal vaginal environment.

The American College of Obstetricians and Gynecologists (ACOG) similarly describes BV as an alteration of the normal vaginal bacterial community rather than simply the presence of a single infectious agent.

This understanding has expanded the clinical perspective on vaginal health. While identifying relevant microorganisms remains essential, evaluating the broader microbial environment can provide additional information for understanding vaginal health status.

Current approaches are increasingly moving beyond single-target pathogen detection toward a more comprehensive assessment that considers:

• · Changes in vaginal microbial balance
• · Presence of clinically relevant microorganisms
• · Potential antimicrobial resistance mechanisms

This evolution reflects a growing recognition that vaginal health is influenced by the entire microbial ecosystem rather than a single detection result alone.

II. Why Comprehensive Molecular Testing Matters

Vaginal health conditions can involve multiple contributing factors. Similar clinical symptoms may arise from different microbial profiles, and microbial changes may influence disease recurrence and treatment considerations.

A comprehensive molecular approach can help laboratories obtain more detailed information by integrating multiple diagnostic dimensions within one workflow.

The Macro & Micro-Test Women’s Health Advanced Nucleic Acid Detection Kit combines:

1. Vaginal Microbiota Assessment

Provides information related to microbial community characteristics and supports evaluation of vaginal microbial balance.

2. Opportunistic Pathogen Detection

Enables simultaneous detection of clinically relevant microorganisms associated with vaginal health conditions.

3. Antimicrobial Resistance Marker Analysis

Provides additional molecular insights into resistance-associated genes to support antimicrobial stewardship.

By combining these capabilities, the solution helps bridge the gap between conventional testing and the increasing demand for comprehensive molecular insights.

III. Supporting Antimicrobial Stewardship Through Molecular Insights

Antimicrobial resistance (AMR) has become a major global public health concern.

According to the World Health Organization (WHO), appropriate antimicrobial use and improved diagnostic capabilities are essential components of addressing AMR challenges.

In women’s health, understanding potential resistance mechanisms may provide additional information when evaluating treatment options and managing recurrent conditions.

The Macro & Micro-Test Women’s Health Advanced Nucleic Acid Detection Kit includes detection of clinically relevant resistance markers:

• · TetM — associated with tetracycline resistance mechanisms
• · ermB — associated with macrolide-lincosamide-streptogramin resistance mechanisms
• · mefA — associated with macrolide resistance mechanisms
• · blaTEM — associated with beta-lactam resistance mechanisms

By integrating AMR marker analysis with microbial detection, this solution supports a more complete molecular assessment and contributes to informed antimicrobial management strategies.

IV. Macro & Micro-Test Women’s Health Advanced Nucleic Acid Detection Kit

One Assay. Comprehensive Vaginal Health Insights.

Designed for modern molecular diagnostics, the Women’s Health Advanced Nucleic Acid Detection Kit provides:

Comprehensive 20-Target Detection

Simultaneous detection of vaginal microbiota-associated microorganisms, opportunistic pathogens, and antimicrobial resistance markers.

Integrated Microbiome and Pathogen Assessment

Supports evaluation of microbial balance while identifying clinically relevant microorganisms.

AMR-Related Molecular Insights

Includes detection of TetM, ermB, mefA, and blaTEM resistance markers.

High Analytical Sensitivity

Limit of detection (LOD): 800 copies/mL

Flexible Platform Compatibility

Compatible with mainstream real-time PCR platforms and sample-to-Result fully automated Macro & Micro-Test Eudemon™ AIO800 molecular diagnostic system.

Convenient Sample Type

Applicable sample: Female cervical/vaginal swab

Stable Storage and Transportation

Storage condition: 2–25°C
Shelf life: 12 months

V. Bridging Guidelines and Clinical Practice

With BV affecting a significant proportion of reproductive-age women worldwide, recurrence remaining a clinical challenge, and antimicrobial resistance continuing to impact infectious disease management, comprehensive diagnostic approaches are becoming increasingly important.

The Macro & Micro-Test Women’s Health Advanced Nucleic Acid Detection Kit represents a new generation of molecular testing designed to align with the evolving understanding of vaginal health.

By integrating:Microbiome Assessment + Pathogen Detection + AMR Analysis, the solution helps laboratories and healthcare professionals gain a more complete understanding of vaginal health, supporting more informed diagnostic evaluation and clinical decision-making.

Women’s health is not defined by a single microorganism.

It is shaped by the complex relationship between microbial communities, clinical conditions, and individual health.

Beyond infection. Toward a comprehensive understanding of women’s vaginal health.